Market Value141,329,716
Total Holdings79
File Date2026-04-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARDX / Ardelyx, Inc.
VRDN / Viridian Therapeutics, Inc.
CGON / CG Oncology, Inc.
LQDA / Liquidia Corporation
MLYS / Mineralys Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
JAZZ / Jazz Pharmaceuticals plc
BEAM / Beam Therapeutics Inc.
BLTE / Belite Bio, Inc - Depositary Receipt (Common Stock)
TERN / Terns Pharmaceuticals, Inc.
PVLA / Palvella Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
ALMS / Alumis Inc.
ACLX / Arcellx, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ROIV / Roivant Sciences Ltd.
MNMD / Mind Medicine (MindMed) Inc.
UPB / Upstream Bio, Inc.
INSM / Insmed Incorporated
VERA / Vera Therapeutics, Inc.
EYPT / EyePoint, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
HRMY / Harmony Biosciences Holdings, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
DFTX / Definium Therapeutics, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
NRIX / Nurix Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
PTCT / PTC Therapeutics, Inc.
RPRX / Royalty Pharma plc
SYRE / Spyre Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
MAZE / Maze Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
SUPN / Supernus Pharmaceuticals, Inc.
XENE / Xenon Pharmaceuticals Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
DNLI / Denali Therapeutics Inc.
TVTX / Travere Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
CELC / Celcuity Inc.
CLDX / Celldex Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
PHVS / Pharvaris N.V.
TGTX / TG Therapeutics, Inc.
ZYME / Zymeworks Inc.
ASND / Ascendis Pharma A/S
ARGX / argenx SE - Depositary Receipt (Common Stock)
DNTH / Dianthus Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
VKTX / Viking Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
HALO / Halozyme Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
IMNM / Immunome, Inc.
IMVT / Immunovant, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
KYMR / Kymera Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
NAMS / NewAmsterdam Pharma Company N.V.
RAPP / Rapport Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
PTGX / Protagonist Therapeutics, Inc.
EXEL / Exelixis, Inc.
KNSA / Kiniksa Pharmaceuticals International, plc
ALNY / Alnylam Pharmaceuticals, Inc.
CYTK / Cytokinetics, Incorporated
COGT / Cogent Biosciences, Inc.
ALKS / Alkermes plc
KOD / Kodiak Sciences Inc.
INBX / Inhibrx Biosciences, Inc.
STOK / Stoke Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
IRON / Disc Medicine, Inc.
TRVI / Trevi Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
RVMD / Revolution Medicines, Inc.
EWTX / Edgewise Therapeutics, Inc.
AGIO / Agios Pharmaceuticals, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
KALV / KalVista Pharmaceuticals, Inc.
ERAS / Erasca, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
SERA / Sera Prognostics, Inc.
ELVN / Enliven Therapeutics, Inc.
UTHR / United Therapeutics Corporation
SMMT / Summit Therapeutics Inc.
NTLA / Intellia Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF
BBIO / BridgeBio Pharma, Inc.
AXSM / Axsome Therapeutics, Inc.
SGOV / iShares Trust - iShares 0-3 Month Treasury Bond ETF
ORKA / Oruka Therapeutics, Inc.
CMPX / Compass Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
INCY / Incyte Corporation